Back to results
US 2026/0176188 A1Published application
Glass tube and pharmaceutical container
AssigneeNippon Electric Glass Co., Ltd.
InventorSatoshi ARAI
Life of this patent
Estimating the term…
Abstract
A glass tube according to the present invention contains, as a glass composition, in mol %, from 60% to 85% of SiO2, from 1% to 20% of Al2O3, from 0% to 5% of B2O3, from 1% to 20% of Li2O+Na2O+K2O, and from 0% to 5% of MgO+CaO+SrO+BaO.
Claims16
1:
- A glass tube comprising, as a glass composition, in mol %, from 60% to 85% of SiO2, from 1% to 20% of Al2O3, from 0% to 5% of B2O3, from 0% to 5% of MgO+CaO+SrO+BaO, and from 1% to 20% of Li2O+Na2O+K2O.
2:
- The glass tube according to claim 1, wherein the content of Al2O3 is from 1 mol % to 10 mol %.
3:
- The glass tube according to claim 1, wherein a content of MgO is from 0 mol % to 1 mol %, and a content of CaO is from 0 mol % to 0.5 mol %.
4:
- The glass tube according to claim 1, wherein a content of Li2O is from 0 mol % to 10 mol %, a content of Na2O is from 0.1 mol % to 15 mol %, and a content of K2O is from 0 mol % to 5 mol %.
5:
- The glass tube according to claim 1, wherein a content of SnO2 is from 0.03 mol % to 3 mol %.
6:
- The glass tube according to claim 1, wherein a content of TiO2 is from 0.001 mol % to 0.5 mol %.
7:
- The glass tube according to claim 1, wherein a content of Fe2O3+TiO2+SnO2+MoO3 is from 0.001 mol % to 1 mol %.
8:
- The glass tube according to claim 1, wherein a molar ratio (Li2O+Na2O+K2O)/Al2O3 is 2 or more.
9:
- The glass tube according to claim 1, wherein a molar ratio MoO3/(Fe2O3+TiO2) is 0.5 or less, and a visible light transmittance at a thickness of 1 mm is 80% or more.
10:
- The glass tube according to claim 1, wherein a molar ratio (10×SnO2)/(10×Fe2O3+TiO2+10×SnO2+100×MoO3) is from 0.5 to 1, and a visible light transmittance at a thickness of 1 mm is 85% or more.
11:
- The glass tube according to claim 1, which is to be subjected to an ion exchange treatment.
12:
- The glass tube according to claim 1, which is for use in a pharmaceutical container.
13:
- A pharmaceutical container obtained by processing a glass tube, wherein
- the glass tube is the glass tube according to claim 1.
14:
- The pharmaceutical container according to claim 13, comprising:
- a compression stress layer on a surface.
15:
- A glass tube comprising, as a glass composition, in mol %, from 66% to 85% of SiO2, from 1% to 10% of Al2O3, from 0% to 5% of B2O3, from 1% to 16.5% of Li2O+Na2O+K2O, from 0% to 5% of MgO+CaO+SrO+BaO, and from 0.03% to 3% of SnO2, wherein a molar ratio MoO3/(Fe2O3+TiO2) is from 0.0001 to 0.2, and a visible light transmittance at a thickness of 1 mm is 85% or more.
16:
- A glass tube comprising, as a glass composition, in mol %, from 66% to 85% of SiO2, from 1% to 10% of Al2O3, from 0% to 5% of B2O3, from 1% to 16.5% of Li2O+Na2O+K2O, from 0% to less than 4% of MgO+CaO+SrO+BaO, from 0.001% to 0.5% of TiO2, and from 0.03% to 3% of SnO2, wherein a molar ratio (10×SnO2)/(10×Fe2O3+TiO2+10×SnO2+100×MoO3) is from 0.5 to 1, and a visible light transmittance at a thickness of 1 mm is 85% or more.